Two more biopharma companies—the hair-growth specialist Veradermics and cancer-focused Eikon Therapeutics—have announced ...
Biopharmaceutical company Agomab Therapeutics filed for an initial public offering in the United States on Friday.
Stoke Therapeutics advances TANGO ASO for Dravet, with Zorevunersen Phase 3 data showing seizure reduction and a delayed 2027 ...
Commercial launch in Switzerland anticipated in H2 2026Pratteln, Switzerland, January 15, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces ...
Stocktwits on MSN
TG Therapeutics stock pops as Briumvi boom reignites bull case: Goldman Sachs sees room for 32% rally
Goldman Sachs raised its price target on TG Therapeutics to $39 from $37 and maintained a ‘neutral’ rating, according to TheFly. ・CEO Michael S. Weiss said that Briumvi was now available in 16 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback